VIAL
VIAL TRUST REPORTTRUST SCORE

Direct Peptides

32/100
Provisional
grey market vendor · TX
ProvisionalCanonical compliance scan pending. We're verifying federal records (FDA, OIG, NPI, DEA) against this provider's claims. The number above is a working estimate.
getvial.com/report/direct-peptides · Generated May 21, 2026
0100
View full provider profile →
Significant Concerns
Significant compliance concerns or sparse public records. Proceed with caution and verify directly.
WHAT INCREASES CONFIDENCE
  • No FDA, DEA, or OIG enforcement actions
  • Operates in 50 states
  • Pricing publicly disclosed
FOLLOW-UP RECOMMENDED
  • Physician credentials not publicly disclosed
  • NPI not confirmed in federal registry
  • Operating history not documented
VIAL ASSESSMENT

Direct Peptides carries enough negative compliance signals — or has so little public disclosure — that Vial recommends caution. Verify federal registration, prescribing licensure, and pharmacy partner status directly with the provider before proceeding.

Share
SCORE DRIVERS
Biggest positive factors
  • No OIG exclusion on record
    HIGH
  • No FDA enforcement actions identified
    HIGH
  • No DEA enforcement actions identified
    HIGH
Biggest negative factors
  • Physician credentials not publicly disclosed
    HIGH
  • NPI registration not confirmed
    MOD
  • Operating history undocumented
    MOD
WHAT WE EVALUATED
  • FDA enforcement recordNo actions identified
  • DEA enforcement recordNo actions identified
  • Prescriber DEA registrationNo flags
  • OIG exclusion statusNot on exclusion list
  • Physician credentialsNot publicly named
  • Pricing transparencyPremium (publicly disclosed)
  • Pharmacy partnerNot publicly named
  • Operating historyNot documented
  • Ownership structurePrivately held
WHAT THIS MEANS

This provider's federal NPI registration could not be confirmed. Ask for the prescribing physician's NPI directly.

No FDA enforcement actions are on record for this provider in the public openFDA database.

Some legitimate providers — particularly newer brands and small practices — have minimal public records. This isn't proof of risk, but it does mean trust has to be established directly with the provider rather than via federal databases.

BEFORE YOU PAY, ASK
  1. 01Who is medically responsible for prescribing decisions, and what are their credentials?
  2. 02What is the all-in cost of the protocol you're recommending?
  3. 03What documentation can you provide to back the compliance claims on your website?
  4. 04What happens to my care and prescriptions if I want to discontinue?
REPORT HISTORY
May 21, 2026· Last verification · score unchanged
Are you Direct Peptides?
Claim this profile to add disclosures, or dispute findings with documentation.
ClaimDispute

Vial verifies provider claims against federal and state regulatory records. We track what’s disclosed and what isn’t.

Sources: FDA · DEA · NPI Registry · OIG · PCAB · State pharmacy boards · Public records · Methodology

This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.